A phase Ia study of seven dose levels of LX 2931 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Apr 2008
At a glance
- Drugs LX 2931 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Lexicon Pharmaceuticals
- 17 Apr 2008 Positive results have been reported in a Lexicon media release.
- 16 Nov 2007 New trial record.
- 12 Nov 2007 IND application submitted to US FDA.